PerkinElmer Expands its OneSource® Laboratory Services with Acquisition of LabMetrix Technologies
News Apr 01, 2008
PerkinElmer, Inc. has announced the acquisition of LabMetrix Technologies, the largest independent provider of metrology-based multi-vendor analytical instrument qualification solutions.
The acquisition of LabMetrix adds technology, tools, proven processes and compliance expertise to PerkinElmer’s suite of OneSource® laboratory services, strengthening its support of customers in a wide range of industries including pharmaceutical, medical device, food, toy and other consumer goods. The terms of the deal were not disclosed.
“This acquisition expands our support of customers in regulated markets by combining metrology-based multi-vendor qualification solutions with PerkinElmer’s existing services capabilities,” said Robert F. Friel, president and chief executive officer, PerkinElmer.
“With the addition of LabMetrix’s technology-assisted compliance solution, we can provide customers with the most robust qualification environment available for a broad range of instruments and technologies in their labs, regardless of manufacturer.”
Greater public attention on product safety coupled with customers’ increased need for improved scientific output continue to drive greater demand for comprehensive regulatory compliance solutions.
According to PerkinElmer, the combination of LabMetrix’s technology solutions with its existing OneSource offerings will make it easier for customers to demonstrate the accuracy of their analytical measurements while helping drive down the cost of compliance through automation, standardization and streamlined documentation. LabMetrix generated revenues of approximately $5 million in 2007.
Genome-wide association studies (GWAS) look at large populations to find genes that contribute to common, multi-gene traits like height or obesity. These comprehensive studies frequently turn up large numbers of tiny genetic variations that occur more often in people who are tall, obese, etc. So which genes should scientists investigate further?READ MORE
In recent years, numerous studies have shown that people who don't get enough sleep are at greater risk of stroke and heart attack. A study found that people who sleep fewer than 7 hours per night have lower blood levels of three physiological regulators, or microRNAs, which influence gene expression and play a key role in maintaining vascular health.